Abstract
Cyclooxygenases and lipoxygenase are key enzymes in the arachidonic acid metabolism. Dual inhibitors are drugs able to block both the COX and the 5-LOX metabolic pathways. Compared to COX or LOX pathways single inhibitors, dual inhibitors present at least two major advantages. First, dual inhibitors, by acting on the two major arachidonic acid metabolic pathways, possess a wide range of anti-inflammatory activities. Secondly, dual inhibitors appear to be almost exempt from gastric toxicity, which is the most troublesome side effect of non-selective COX inhibitors.
Keywords: cancer, cyclooxygenases, dual inhibitors, inflammation, leukotrienes
Mini-Reviews in Medicinal Chemistry
Title: Recent Development in the Field of Dual COX / 5-LOX Inhibitors
Volume: 4 Issue: 6
Author(s): Fabien Julemont, Jean-Michel Dogne, Bernard Pirotte and Xavier de Leval
Affiliation:
Keywords: cancer, cyclooxygenases, dual inhibitors, inflammation, leukotrienes
Abstract: Cyclooxygenases and lipoxygenase are key enzymes in the arachidonic acid metabolism. Dual inhibitors are drugs able to block both the COX and the 5-LOX metabolic pathways. Compared to COX or LOX pathways single inhibitors, dual inhibitors present at least two major advantages. First, dual inhibitors, by acting on the two major arachidonic acid metabolic pathways, possess a wide range of anti-inflammatory activities. Secondly, dual inhibitors appear to be almost exempt from gastric toxicity, which is the most troublesome side effect of non-selective COX inhibitors.
Export Options
About this article
Cite this article as:
Julemont Fabien, Dogne Jean-Michel, Pirotte Bernard and Leval de Xavier, Recent Development in the Field of Dual COX / 5-LOX Inhibitors, Mini-Reviews in Medicinal Chemistry 2004; 4 (6) . https://dx.doi.org/10.2174/1389557043403747
DOI https://dx.doi.org/10.2174/1389557043403747 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin, a Potential Therapeutic Agent for Smooth Muscle-Related Pathological Conditions and Aging
Current Medicinal Chemistry Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome
Current Pharmacogenomics and Personalized Medicine Gene therapy for Multiple Myeloma
Current Gene Therapy Modeling Anti-Allergic Natural Compounds by Molecular Topology
Combinatorial Chemistry & High Throughput Screening 5-Adenosine Monophosphate-Activated Protein Kinase and the Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Vaccination Against High Blood Pressure
Current Pharmaceutical Design Flavonoids, Vascular Function and Cardiovascular Protection
Current Pharmaceutical Design Epitope Mapping and Identification of Amino Acids Critical for Rabbits IgG-Binding to Linear Epitopes on Buffalo beta-lactoglobulin
Protein & Peptide Letters Gene Therapy for Familial Hypercholesterolemia
Current Pharmaceutical Design The Inhibitory Role of M2000 (β-D-Mannuronic Acid) on Expression of Toll-like Receptor 2 and 4 in HT29 Cell Line
Recent Patents on Inflammation & Allergy Drug Discovery Immunotherapy in Gastric Carcinoma: Current Status and Future Perspectives
Clinical Cancer Drugs Role of Cytokines in Allograft Rejection
Current Pharmaceutical Design Pharmacological and Clinical Applications of Natriuretic Peptides: Accepted Knowledges or Changing Views?
Current Pharmaceutical Analysis Neural Progenitors and HIV-1- Associated Central Nervous System Disease in Adults and Children
Current HIV Research Host Restriction Factors and Human Immunodeficiency Virus (HIV-1): A Dynamic Interplay Involving All Phases of the Viral Life Cycle
Current HIV Research ApoB-100 and HSP60 Peptides Exert a Synergetic Role in Inhibiting Early Atherosclerosis in Immunized ApoE-null Mice
Protein & Peptide Letters Imidazoquinolines: Recent Developments in Anticancer Activity
Mini-Reviews in Medicinal Chemistry Role of Heart Rate Reduction in the Management of Myocarditis
Current Pharmaceutical Design Engineering Human Urate Oxidase: Towards Reactivating It as an Important Therapeutic Enzyme
Current Pharmaceutical Biotechnology Artemisinin, Promising Lead Natural Product for Various Drug Developments
Mini-Reviews in Medicinal Chemistry